Testicular degeneration in Huntington disease

Testicular degeneration in Huntington disease

Huntington disease (HD) is an adult onset, neurodegenerative disorder that results from CAG expansion in the HD gene. Recent work has demonstrated testicular degeneration in mouse models of HD and alterations in the hypothalamic–pituitary–gonadal (HPG) axis in HD patients. Here, we show that HD pati...

Full description

Bibliographic Details
Main Authors:	Jeremy M. Van Raamsdonk, Zoe Murphy, David M. Selva, Reza Hamidizadeh, Jacqueline Pearson, Ǻsa Petersén, Maria Björkqvist, Cameron Muir, Ian R. Mackenzie, Geoffrey L. Hammond, A. Wayne Vogl, Michael R. Hayden, Blair R. Leavitt
Format:	Article
Language:	English
Published:	Elsevier 2007-06-01
Series:	Neurobiology of Disease
Subjects:	Huntington disease Huntingtin Testis Hypothalamic–pituitary–gonadal axis Testosterone YAC128 mouse model
Online Access:	http://www.sciencedirect.com/science/article/pii/S0969996107000228

Similar Items

Age-dependent neurovascular abnormalities and altered microglial morphology in the YAC128 mouse model of Huntington disease
by: Sonia Franciosi, et al.
Published: (2012-01-01)

The Generation of Mouse and Human Huntington Disease iPS Cells Suitable for In vitro Studies on Huntingtin Function
by: Wojciech J. Szlachcic, et al.
Published: (2017-08-01)

Corrigendum: The Generation of Mouse and Human Huntington Disease iPS Cells Suitable for In vitro Studies on Huntingtin Function
by: Wojciech J. Szlachcic, et al.
Published: (2017-09-01)

Solid Lipid Curcumin Particles Protect Medium Spiny Neuronal Morphology, and Reduce Learning and Memory Deficits in the YAC128 Mouse Model of Huntington’s Disease
by: Abeer Gharaibeh, et al.
Published: (2020-12-01)

Partial rescue of some features of Huntington Disease in the genetic absence of caspase-6 in YAC128 mice
by: Bibiana K.Y. Wong, et al.
Published: (2015-04-01)

Huntingtin-Associated Protein 1A Regulates Store-Operated Calcium Entry in Medium Spiny Neurons From Transgenic YAC128 Mice, a Model of Huntington’s Disease
by: Magdalena Czeredys, et al.
Published: (2018-10-01)

Temporal Characterization of Behavioral and Hippocampal Dysfunction in the YAC128 Mouse Model of Huntington’s Disease
by: Cristine de Paula Nascimento-Castro, et al.
Published: (2022-06-01)

Palmitoylation and function of glial glutamate transporter-1 is reduced in the YAC128 mouse model of Huntington disease
by: Kun Huang, et al.
Published: (2010-10-01)

Regional vulnerability in Huntington's disease: fMRI-guided molecular analysis in patients and a mouse model of disease
by: Nicole M. Lewandowski, et al.
Published: (2013-04-01)

Altered adult hippocampal neurogenesis in the YAC128 transgenic mouse model of Huntington disease
by: Jessica M. Simpson, et al.
Published: (2011-02-01)

DAPK1 Promotes Extrasynaptic GluN2B Phosphorylation and Striatal Spine Instability in the YAC128 Mouse Model of Huntington Disease
by: Mandi E. Schmidt, et al.
Published: (2020-11-01)

The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease
by: Daniel Ryskamp, et al.
Published: (2017-01-01)

Antisense oligonucleotide-mediated disruption of HTT caspase-6 cleavage site ameliorates the phenotype of YAC128 Huntington disease mice
by: Elsa C. Kuijper, et al.
Published: (2024-01-01)

Induced Pluripotent Stem Cell-Derived Neural Stem Cell Transplantations Reduced Behavioral Deficits and Ameliorated Neuropathological Changes in YAC128 Mouse Model of Huntington's Disease
by: Abeer Al-Gharaibeh, et al.
Published: (2017-11-01)

Levels of mutant huntingtin influence the phenotypic severity of Huntington disease in YAC128 mouse models
by: Rona K. Graham, et al.
Published: (2006-02-01)

Microarray profiling of hypothalamic gene expression changes in Huntington’s disease mouse models
by: Elna Dickson, et al.
Published: (2022-11-01)

A novel function of Huntingtin in the cilium and retinal ciliopathy in Huntington's disease mice
by: Alice Karam, et al.
Published: (2015-08-01)

Huntington’s Disease: Complex Pathogenesis and Therapeutic Strategies
by: Huichun Tong, et al.
Published: (2024-03-01)

Mitochondrial and redox modifications in early stages of Huntington's disease
by: Carla Lopes, et al.
Published: (2022-10-01)

Reducing huntingtin by immunotherapy delays disease progression in a mouse model of Huntington disease
by: Stefan Bartl, et al.
Published: (2024-01-01)

C57BL/6 Background Attenuates mHTT Toxicity in the Striatum of YAC128 Mice
by: Michaela K. Back, et al.
Published: (2021-11-01)

Bypassing mitochondrial defects rescues Huntington's phenotypes in Drosophila
by: Susanna Campesan, et al.
Published: (2023-09-01)

A Mitochondria-Associated Oxidative Stress Perspective on Huntington’s Disease
by: Ju Zheng, et al.
Published: (2018-09-01)

Strategies to Investigate Ubiquitination in Huntington's Disease
by: Karen A. Sap, et al.
Published: (2020-06-01)

Huntington hastalığı tanısı almış hastalarda ve ailelerinde CAG trinükleotid tekrar sayılarının fragman analizi ile tespiti
by: Davut ALPTEKİN, et al.
Published: (2019-06-01)

SUMO-modifying Huntington’s disease
by: Ericks S. Soares, et al.
Published: (2022-06-01)

Therapeutic Advances for Huntington’s Disease
by: Ashok Kumar, et al.
Published: (2020-01-01)

Altering cortical input unmasks synaptic phenotypes in the YAC128 cortico-striatal co-culture model of Huntington disease
by: Mandi E. Schmidt, et al.
Published: (2018-06-01)

Pridopidine protects neurons from mutant-huntingtin toxicity via the sigma-1 receptor
by: Chelsy R. Eddings, et al.
Published: (2019-09-01)

The emerging role of the first 17 amino acids of huntingtin in Huntington’s disease
by: Arndt James R., et al.
Published: (2015-03-01)

Emerging Roles of Exosomes in Huntington’s Disease
by: Hanadi Ananbeh, et al.
Published: (2021-04-01)

Ubiquitin-modifying enzymes in Huntington’s disease
by: Karen A. Sap, et al.
Published: (2023-02-01)

Reactive Species in Huntington Disease: Are They Really the Radicals You Want to Catch?
by: José Bono-Yagüe, et al.
Published: (2020-07-01)

The distribution and density of Huntingtin inclusions across the Huntington disease neocortex: regional correlations with Huntingtin repeat expansion independent of pathologic grade
by: Richard A. Hickman, et al.
Published: (2022-04-01)

Oxytocin in Huntington’s disease and the spectrum of amyotrophic lateral sclerosis-frontotemporal dementia
by: Sofia Bergh, et al.
Published: (2022-09-01)

Implications of the Orb2 Amyloid Structure in Huntington’s Disease
by: Rubén Hervás, et al.
Published: (2020-09-01)

Studying Huntington’s Disease in Yeast: From Mechanisms to Pharmacological Approaches
by: Sebastian Hofer, et al.
Published: (2018-09-01)

Molecular Pathophysiological Mechanisms in Huntington’s Disease
by: Anamaria Jurcau
Published: (2022-06-01)

Amplification of neurotoxic HTTex1 assemblies in human neurons
by: Anjalika Chongtham, et al.
Published: (2021-11-01)

HAP40 protein levels are huntingtin-dependent and decrease in Huntington disease
by: Bin Huang, et al.
Published: (2021-10-01)